Research output per year
Research output per year
Personal profile
Ancillary activities
No ancillary activities
Ancillary activities are updated daily
Fingerprint
Dive into the research topics where Kenneth Fernald is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance
Fernald, K. D. S., Pennings, H. P. G., van den Bosch, J. F., Commandeur, H. R. & Claassen, H. J. H. M., 23 Feb 2017, In: PLoS ONE. 12, 2, p. e0172488 e0172488.Research output: Contribution to Journal › Article › Academic › peer-review
Open Access -
Biotechnology Commercialization Strategies: Risk and Return in Interfirm Cooperation
Fernald, K. D. S., Pennings, H. P. G. & Claassen, E., Nov 2015, In: Journal of Product Innovation Management. 32, 6, p. 971-996 26 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
Trade-sale exits in different biotech sectors
Fernald, K. D. S. & Claassen, E., 2015, In: Nature Biotechnology. 33, p. 1221-1239Research output: Contribution to Journal › Article › Academic › peer-review
-
Venture capitalists as gatekeepers for biotechnological innovation
Fernald, K., Hoeben, R. & Claassen, H. J. H. M., 1 Jul 2015, In: Journal of Commercial Biotechnology. 21, 3, p. 32-41 10 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
Bridging a pharma-like innovation gap in medical nutrition.
Pronker, E. S., Weenen, T. C., Fernald, K. D. S., Claassen, E. & Commandeur, H., 2014, Advances in Pharmaceutical Sciences, Pharma Nutrition. Lipper Crommelin, D. (ed.). Springer, p. 29-52-3Research output: Chapter in Book / Report / Conference proceeding › Chapter › Academic › peer-review